Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07460726) titled 'PRIAPUS-PCa Study: Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) Impact on Sexual Function on Men With Unfavorable Intermediate Risk Prostate Cancer' on Feb. 25.
Study Type: Observational [Patient Registry]
Primary Sponsor: CancerCare Manitoba
Condition:
Prostate Cancer (Adenocarcinoma)
Erectile Abnormalities
Sexual Dysfunction Male
Intervention:
Combination Product: SBRT combined with ADT
Recruitment Status: Not recruiting
Date of First Enrollment: March 16, 2026
Target Sample Size: 130
Countries of Recruitment:
Canada
To know more, visit https://clinicaltrials.gov/st...